Biotech

All Articles

ArsenalBio raises $325M, pivots far from former lead possession

.Toolbox Biosciences is moving on up. The tissue therapy provider has actually added on $325 thousan...

Lilly- supported weight loss biotech reports IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis make use of medicine flunks period 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's chances of getting a fast, good decision on a $one hundred million choice payment hav...

ProKidney standstills period 3 test not required for tissue therapy authorization

.ProKidney has actually stopped one of a set of period 3 tests for its cell treatment for renal dise...

Vaxcyte rises on 'sensational' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what analysts named "remarkable" stage 1/2 information for its own 31-valent pneum...

Recursion's mind disease test presents insufficient proof of efficacy

.Recursion has actually stumbled by means of a very early exam of its tech-enabled approach to medic...

Acepodia, Pfizer click on with each other for chemistry-based cell treatment

.Phone it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning s...

Praxis epilepsy medication reduces confiscations in stage 2 hearing

.Praxis Precision Medicines has racked up an additional midphase succeed in epilepsy this year, with...

Three officers surrender as Dyne articles combined information for DMD applicant

.After running away a medical grip a number of years back, Dyne Therapeutics has actually disclosed ...

Arrowhead fires off period 3 records in rare metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand before a prospective showdown with Ionis, posting stag...